E. Rubin

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

R. Mayer, R. Stone, E. Rubin, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.

J. Thompson, John A Thompson, D. Lee, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-time chemotherapy or high time for low dose.

E Glatstein, E. Glatstein, J. Aisner, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.

J. Thompson, A. Fefer, P. Kidd, 1989, Blood.

Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.

A. Shields, J. Thompson, B. Porter, 1987, Leukemia.

Very low dose alpha-2b interferon for the treatment of hairy cell leukemia [see comments]

A. Fefer, P. Kidd, E. Rubin, 1989 .